Cellular prion protein overexpression disturbs cellular homeostasis in SH-SY5Y neuroblastoma cells but does not alter p53 expression: A proteomic study

Neuroscience

Volumn 169, Issue 4, 2010, Pages 1640-1650

  Weiss, E ^a   Ramljak, S ^a,c   Asif, A R ^b   Ciesielczyk, B ^a   Schmitz, M ^a   Gawinecka, J ^a   Schulz Schaeffer, W ^b   Behrens, C ^b   Zerr, I ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

Author keywords

Annexin V; Cytoskeleton; Prion protein; Protein folding; Signal transduction; Transgelin 2

Indexed keywords

LIPOCORTIN 5; NUCLEIC ACID BINDING PROTEIN; POLYGLUTAMINE TRACT BINDING PROTEIN 1; PRION PROTEIN; PROTEIN P53; SPERMINE SYNTHASE; TRANSGELIN; TRANSGELIN 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; CYTOSKELETON; HOMEOSTASIS; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 77955427581     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.013     Document Type: Article

References (68)

1. Bera A., Nandi P.K. Biological polyamines inhibit nucleic-acid-induced polymerisation of prion protein. Arch Virol 2007, 152:655-668.
2. Bounhar Y., Zhang Y., Goodyer C.G., LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 2001, 276:39145-39149.
3. Brignone C., Bradley K.E., Kisselev A.F., Grossman S.R. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway. Oncogene 2004, 23:4121-4129.
4. Brown D.R., Besinger A. Prion protein expression and superoxide dismutase activity. Biochem J 1998, 334:423-429.
5. Chen S., Mangé A., Dong L., Lehmann S., Schachner M. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 2003, 22:227-233.
6. Chiesa R., Piccardo P., Biasini E., Ghetti B., Harris D.A. Aggregated, wild type prion protein causes neurological dysfunction and synaptic abnormalities. J Neurosci 2008, 28:13258-13267.
7. Cohen E., Taraboulos A. Scrapie-like protein accumulates in aggresomes of cyclosporine A-treated cells. EMBO J 2003, 22:404-417.
8. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., Jefferys J.G. Prion protein is necessary for normal synaptic function. Nature 1994, 370:295-297.
9. Coso O.A., Chiariello M., Yu J.C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J.S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995, 81:1137-1146.
10. Di Pietro E., Sirois J., Tremblay M.L., MacKenzie R.E. Mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is essential for embryonic development. Mol Cell Biol 2002, 22:4158-4166.
11. Domingo M.T., Spinnewyn B., Chabrier P.E., Braquet P. Presence of specific binding sites for platelet-activating factor (PAF) in brain. Biochem Biophys Res Commun 1988, 151:730-736.
12. Dong C.F., Shi S., Wang X.F., An R., Li P., Chen J.M., Wang X., Wang G.R., Shan B., Zhang B.Y., Han J., Dong X.P. The N-terminus of PrP is responsible for interacting with tubulin and fCJD related PrP mutants possess stronger inhibitive effect on microtubule assembly in vitro. Arch Biochem Biophys 2008, 470:83-92.
13. Dupiereux I., Zorzi W., Rachidi W., Zorzi D., Pierard O., Lhereux B., Heinen E., Elmoualij B. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells. J Neurosci Res 2006, 84:637-646.
14. Fu H., Subramanian R.R., Masters S.C. 14-3-3 proteins: structure, function and regulation. Annu Rev Pharmacol Toxicol 2000, 40:617-647.
15. Gachet Y., Tournier S., Lee M., Lazaris-Karatzas A., Poulton T., Bommer U.A. The growth-related, translationally controlled protein P23 has properties of a tubulin finding protein and associates transiently with microtubules during the cell cycle. J Cell Sci 1999, 112:1257-1271.
16. Glockzin S., Ogi F.X., Hengstermann A., Scheffner M., Blattner C. Involvement of the DNA repair protein hHR23 in p53 degradation. Mol Cell Biol 2003, 23:8960-8969.
17. Goodman A., Goode B.L., Matsudaira P., Fink G.R. The Saccharomyces cerevisiae calponin/transgelin homolog Scp1 functions with fimbrin to regulate stability and organization of the actin cytoskeleton. Mol Biol Cell 2003, 14:2617-2629.
18. Gourlay C.W., Carpp L.N., Timpson P., Winder S.J., Ayscough K.R. A role for the actin cytoskeleton in cell death and aging in yeast. J Cell Biol 2004, 164:803-809.
19. Ha H.C., Sirisoma N.S., Kuppusamy P., Zweier J.L., Woster P.M., Casero R.A. The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci U S A 1998, 95:11140-11145.
20. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
21. Hattori M., Arai H., Inoue K. Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J Biol Chem 1993, 268:18748-18753.
22. 2+-dependent apoptosis. Proc Natl Acad Sci U S A 2002, 99:8054-8059.
23. Huang S., Liang J., Zheng M., Li X., Wang M., Wang P., Vanegas D., Wu D., Chakraborty B., Hays A.P., Chen K., Chen S.G., Booth S., Cohen M., Gambetti P., Kong Q. Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice. Proc Natl Acad Sci U S A 2007, 104:6800-6805.
24. Jung J., Kim M., Kim M.J., Kim J., Moon J., Lim J.S., Kim M., Lee K. Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells. J Biol Chem 2004, 279:49868-49875.
25. Kim M.J., Kwon J.S., Suh S.H., Suh J.K., Jung J., Lee S.N., Kim Y.H., Cho M.C., Oh G.T., Lee K. Transgenic overexpression of translationally controlled tumor protein induces systemic hypertension via repression of Na+,K+-ATPase. J Mol Cell Cardiol 2008, 44:151-159.
26. Kramer M.L., Kratzin H.D., Schmidt B., Römer A., Windl O., Liemann S., Hornemann S., Kretzschmar H. Prion protein binds copper within the physiological concentration range. J Biol Chem 2001, 276:16711-16719.
27. Krasemann S., Jürgens T., Bodemer W. Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy. J Biotechnol 1999, 73:119-129.
28. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Yokoyama T., Itohara S., Onodera T. Prions prevent neuronal cell-line death. Nature 1999, 400:225-226.
29. Le Clainche C., Carlier M.F. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev 2008, 88:489-513.
30. Liang J., Parchaliuk D., Medina S., Sorensen G., Landry L., Huang S., Wang M., Kong Q., Booth S.A. Activation of p53-regulated pro-apoptotic pathways in PrP-mediated myopathy. BMC Genomics 2009, 10:201.
31. Málaga-Trillo E., Solis G.P., Schrock Y., Geiss C., Luncz L., Thomanetz V., Stuermer C.A. Regulation of embryonic cell adhesion by the prion protein. PLoS Biol 2009, 7:e55.
32. Marcheselli V.L., Rossowska M.J., Domingo M.T., Braquet P., Bazan N.G. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem 1990, 265:9140-9145.
33. Martínez T., Pascual A. Identification of genes differentially expressed in SH-SY5Y neuroblastoma cells exposed to the prion peptide 106-126. Eur J Neurosci 2007, 26:51-59.
34. Marubuchi S., Wada Y., Okuda T., Hara Y., Qi M.L., Hoshino M., Nakagawa M., Kanazawa I., Okazawa H. Polyglutamine tract-binding protein-1 dysfunction induces cell death of neurons through mitochondrial stress. J Neurochem 2005, 95:858-870.
35. Minden A., Lin A., Claret F.X., Abo A., Karin M. Selective activation of the JNK signalling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 1995, 81:1147-1157.
36. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., Kellermann O. Signal transduction through prion protein. Science 2000, 289:1925-1928.
37. Müller T., Concannon C.G., Ward M.W., Walsh C.M., Tirniceriu A.L., Tribl F., Kögel D., Prehn J.H., Egensperger R. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell 2007, 18:201-210.
38. Nair R.R., Solway J., Boyd D.D. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem 2006, 281:26424-26436.
39. Nieznanski K., Podlubnaya Z.A., Nieznanska H. Prion protein inhibits microtubule assembly by inducing tubulin oligomerization. Biochem Biophys Res Commun 2006, 349:391-399.
40. Okuda T., Hattori H., Takeuchi S., Shimizu J., Ueda H., Palvimo J.J., Kanazawa I., Kawano H., Nakagawa M., Okazawa H. PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype. Hum Mol Genet 2003, 12:711-725.
41. c triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti-PrP antibodies. J Neurochem 2002, 83:1208-1214.
42. Paitel E., Fahraeus R., Checler F. Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation. J Biol Chem 2003, 278:10061-10066.
43. Paitel E., Sunyach C., Alves da Costa C., Bourdon J.C., Vincent B., Checler F. Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J Biol Chem 2004, 279:612-618.
44. Pauly P.C., Harris D.A. Copper stimulates endocytosis of the prion protein. J Biol Chem 1998, 273:33107-33110.
45. Pegg A.E., McCann P.P. Polyamine metabolism and function. Am J Physiol 1982, 243:C212-C221.
46. c. Proteomics 2006, 6:6476-6484.
47. Pradines E., Loubet D., Schneider B., Launay J.M., Kellermann O., Mouillet-Richard S. CREB-dependent gene regulation by prion protein: impact on MMP-9 and beta-dystroglycan. Cell Signal 2008, 20:2050-2058.
48. Prescott S.M., Zimmerman G.A., Stafforini D.M., McIntyre T.M. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000, 69:419-445.
49. c): protein profiling study in two cell culture systems. J Proteome Res 2008, 7:2681-2695.
50. Sanchez E.R. Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J Biol Chem 1990, 265:22067-22070.
51. Satoh J., Obayashi S., Misawa T., Sumiyoshi K., Oosumi K., Tabunoki H. Protein microarray analysis identifies human cellular prion protein interactors. Neuropathol Appl Neurobiol 2009, 35:16-35.
52. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
53. c directly interacts with proteins involved in signaling pathways. J Biol Chem 2001, 276:44604-44612.
54. Steinacker P., Schwarz P., Reim K., Brechlin P., Jahn O., Kratzin H., Aitken A., Wiltfang J., Aguzzi A., Bahn E., Baxter H.C., Brose N., Otto M. Unchanged survival rates of 14-3-3gamma knockout mice after inoculation with pathological prion protein. Mol Cell Biol 2005, 25:1339-1346.
55. Sugasawa K., Masutani C., Uchida A., Maekawa T., van der Spek P.J., Bootsma D., Hoeijmakers J.H., Hanaoka F. HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro. Mol Cell Biol 1996, 16:4852-4861.
56. Sunyach C., Cisse M.A., da Costa C.A., Vincent B., Checler F. The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J Biol Chem 2007, 282:1956-1963.
57. Van Everbroeck B.R., Boons J., Cras P. 14-3-3 {gamma}-isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementias. J Neurol Neurosurg Psychiatry 2005, 76:100-102.
58. Vassallo N., Herms J., Behrens C., Krebs B., Saeki K., Onodera T., Windl O., Kretzschmar H.A. Activation of phosphatidylinositol 3-kinase by cellular prion protein and its role in cell survival. Biochem Biophys Res Commun 2005, 332:75-82.
59. Walz R., Amaral O.B., Rockenbach I.C., Roesler R., Izquierdo I., Cavalheiro E.A., Martins V.R., Brentani R.R. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999, 40:1679-1682.
60. Wang W., Kirsch T. Annexin V/beta 5 integrin interactions regulate apoptosis of growth plate chondrocytes. J Biol Chem 2006, 281:30848-30856.
61. Waragai M., Lammers C.H., Takeuchi S., Imafuku I., Udagawa Y., Kanazawa I., Kawabata M., Mouradian M.M., Okazawa H. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum Mol Genet 1999, 8:977-987.
62. Watt N.T., Routledge M.N., Wild C.P., Hooper N.M. Cellular prion protein protects against reactive-oxygen-species-induced DNA damage. Free Radic Biol Med 2007, 43:959-967.
63. c) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 2004, 372:146-150.
64. Westaway D., DeArmond S.J., Cayetano-Canlas J., Groth D., Foster D., Yang S.L., Torchia M., Carlson G.A., Prusiner S.B. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 1994, 76:117-129.
65. sc in scrapie-infected mouse neuroblastoma cells. Biol Chem 2000, 381:463-469.
66. Wong B.S., Liu T., Li R., Pan T., Petersen R.B., Smith M.A., Gambetti P., Perry G., Manson J.C., Brown D.R., Sy M.S. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 2001, 76:565-572.
67. Xiang W., Windl O., Westner I.M., Neumann M., Zerr I., Lederer R.M., Kretzschmar H.A. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2005, 58:242-257.
68. Yoo B.C., Krapfenbauer K., Cairns N., Belay G., Bajo M., Lubec G. Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett 2002, 334:196-200.